C3 BIO-TECHNOLOGIES LIMITED is a limited company established in 2015, operating from its headquarters at 20 Mannin Way, Lancaster Business Park, Caton Road, Lancaster, LA1 3SW. The company’s SIC codes are -72110, reflecting its primary focus on research and experimental development within the biotechnology sector. C3 Biotech specializes in the development and commercialization of a novel fermentation platform technology. This platform significantly reduces the capital expenditure and operational expenses associated with traditional biomanufacturing processes. The company’s core service offering centers around the efficient and scalable production of fuels and chemicals, offering a compelling alternative to conventional methods. C3 Biotech’s international presence is actively pursued, demonstrating a commitment to global partnerships and market expansion. The company is currently employing a skilled workforce, with a focus on innovation and strategic growth within the biotechnology industry. The company’s size estimate is currently considered to be mid-sized, indicating a significant investment in research and development. The company’s key focus is on transforming biomanufacturing, prioritizing cost-effectiveness and infrastructure compatibility. Further details can be found on their website: {"company_type": "type", "services": "brief services", "company_size": "size estimate", "key_focus": "biomanufacturing", "international_presence": "yes", "hiring_indicators": "yes"}

C3 BIO-TECHNOLOGIES LIMITED is a limited company established in 2015, operating from its headquarters at 20 Mannin Way, Lancaster Business Park, Caton Road, Lancaster, LA1 3SW. The company’s SIC codes are -72110, reflecting its primary focus on research and experimental development within the biotechnology sector. C3 Biotech specializes in the development and commercialization of a novel fermentation platform technology. This platform significantly reduces the capital expenditure and operational expenses associated with traditional biomanufacturing processes. The company’s core service offering centers around the efficient and scalable production of fuels and chemicals, offering a compelling alternative to conventional methods. C3 Biotech’s international presence is actively pursued, demonstrating a commitment to global partnerships and market expansion. The company is currently employing a skilled workforce, with a focus on innovation and strategic growth within the biotechnology industry. The company’s size estimate is currently considered to be mid-sized, indicating a significant investment in research and development. The company’s key focus is on transforming biomanufacturing, prioritizing cost-effectiveness and infrastructure compatibility. Further details can be found on their website: {"company_type": "type", "services": "brief services", "company_size": "size estimate", "key_focus": "biomanufacturing", "international_presence": "yes", "hiring_indicators": "yes"}